Adynovi

Product Overview

About Adynovi

Adynovi is a medicine used to treat and prevent bleeding in patients with haemophilia A, an inherited bleeding disorder caused by lack of a clotting protein called factor VIII.

What it is used for

It can be used in adults and children from 12 years of age.

How it is used

Adynovi can only be obtained with a prescription and treatment should be under the supervision of a doctor who has experience in the treatment of haemophilia.

Adynovi is available as a powder and solvent that are mixed together to make a solution for injection into a vein.

The dose and frequency of treatment depend on whether it is used to treat or prevent bleeding, as well as on the seriousness of the haemophilia, the extent and location of the bleeding and the patient’s condition and bodyweight.

Patients or their carers may be able to inject Adynovi themselves at home once they have been trained appropriately.

How it works

Patients with haemophilia A lack factor VIII, a protein needed for normal clotting of the blood, and as a result, they bleed readily.

The active substance in Adynovi, rurioctocog alfa pegol, works in the body in the same way as human factor VIII.

It replaces the missing factor VIII, thereby helping the blood to clot and giving temporary control of the bleeding disorder.

Active substance: rurioctocog alfa pegol

Source: EMA EPAR